Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
NEUROCRINE BIOSCIENCES INC
| Metric | NEUROCRINE BIOSCIENCES INC Other |
|---|---|
| Quality Score | 87 / 100 |
| Revenue (latest) | $2.86B |
| Net income (latest) | $479M |
| Operating margin | 21.6% |
| Net margin | 16.7% |
| Return on equity | 14.7% |
| Return on assets | 10.3% |
| Return on capital (ROCE) | 15.9% |
| Debt / equity | 0.42× |
| Revenue growth (YoY) | 21.4% |
| Altman Z″ (distress) | 6.21 |
| Accruals / assets | −6.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.